Hyundai Pharm Net Asset Quality Index
Hyundai Pharm net asset quality index. Hyundai Pharm (004310) has a Net Asset Quality Index of 57.0% as of May 2026. This metric measures the proportion of total assets financed by shareholders' equity — total assets of ₩224.69 Billion minus total liabilities of ₩96.64 Billion yields net assets of ₩128.05 Billion. A higher index indicates a stronger, lower-leverage balance sheet. Check how high is Hyundai Pharm's earnings quality to evaluate the quality of earnings relative to operating cash generation.
Quality Index
Net Assets
Total Assets
Total Liabilities
Net Asset Quality Index of Hyundai Pharm (2010–2025)
Net asset quality index of Hyundai Pharm from 2010 to 2025. This chart shows how Hyundai Pharm's Net Asset Quality Index has evolved across 14 annual periods from 2010 to 2025. As of May 2026, the index stands at 57.0%, representing net assets of ₩128.05 Billion against total assets of ₩224.69 Billion KRW. See Hyundai Pharm (004310) shareholders funds for net asset value and shareholders' equity analysis.
Hyundai Pharm Net Asset Quality Index by Year (2010–2025)
Hyundai Pharm net asset quality index by year from 2010 to 2025. The table below presents the year-by-year Net Asset Quality Index for Hyundai Pharm from 2010 to 2025, covering 14 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. For live market cap and overall valuation, see Hyundai Pharm market capitalisation.
| Year | Quality Index | Net Assets (KRW) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 50.3% | ₩82.10 Billion | ₩163.22 Billion | ₩81.11 Billion | ▼ -0.3 pp |
| 2024 | 50.6% | ₩79.07 Billion | ₩156.40 Billion | ₩77.32 Billion | ▼ -4.2 pp |
| 2023 | 54.8% | ₩84.66 Billion | ₩154.63 Billion | ₩69.97 Billion | ▲ +7.0 pp |
| 2022 | 47.8% | ₩86.56 Billion | ₩181.16 Billion | ₩94.60 Billion | ▼ -5.1 pp |
| 2021 | 52.9% | ₩86.60 Billion | ₩163.86 Billion | ₩77.26 Billion | ▼ -4.4 pp |
| 2020 | 57.2% | ₩90.14 Billion | ₩157.50 Billion | ₩67.36 Billion | ▼ -3.0 pp |
| 2019 | 60.2% | ₩87.58 Billion | ₩145.47 Billion | ₩57.89 Billion | ▼ -7.2 pp |
| 2018 | 67.4% | ₩107.00 Billion | ₩158.80 Billion | ₩51.80 Billion | ▲ +3.9 pp |
| 2017 | 63.4% | ₩98.10 Billion | ₩154.62 Billion | ₩56.52 Billion | ▼ -3.0 pp |
| 2016 | 66.5% | ₩100.08 Billion | ₩150.55 Billion | ₩50.47 Billion | ▼ -4.1 pp |
| 2013 | 70.6% | ₩101.21 Billion | ₩143.40 Billion | ₩42.19 Billion | ▲ +4.1 pp |
| 2012 | 66.5% | ₩99.69 Billion | ₩149.90 Billion | ₩50.22 Billion | ▲ +0.0 pp |
| 2011 | 66.5% | ₩104.32 Billion | ₩156.95 Billion | ₩52.63 Billion | ▼ -4.2 pp |
| 2010 | 70.6% | ₩92.50 Billion | ₩130.98 Billion | ₩38.48 Billion | — |